Clearmind Medicine, Inc. (CMND)
0.0731
0.00 (0.00%)
USD |
NASDAQ |
Dec 12, 12:17
Clearmind Medicine Shareholders Equity (Quarterly): 1.066M for July 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 33.62M |
| Oncolytics Biotech, Inc. | 0.0827M |
| Aurinia Pharmaceuticals, Inc. | 365.77M |
| Edesa Biotech, Inc. | 14.13M |
| Lexaria Bioscience Corp. | 2.990M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.970M |
| Total Liabilities (Quarterly) | 2.904M |
| Debt to Equity Ratio | 0.0266 |
| Current Ratio | 1.316 |
| Net Debt Paydown Yield | -0.11% |